We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brand Firm Avanir Wins Generic Patent Challenge to Nuedexta
Brand Firm Avanir Wins Generic Patent Challenge to Nuedexta
A federal judge has ruled against generic makers Par Pharmaceuticals and Impax Labs in their patent challenges to Avanir Pharmaceuticals’ pseudobulbar affect drug Nuedexta.